Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants

NCT04073459 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

336

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria
Tetanus
Pertussis
Hepatitis B
Poliomyelitis
Haemophilus Influenzae Type b Infection

Interventions

BIOLOGICAL: DTwP-HepB-Sabin IPV-Hib
BIOLOGICAL: Pentavalent vaccine and Salk IPV

Sponsor

LG Chem